Funds holding Gongwin Biopharm Holdings Co Ltd
ISIN KYG409471060 · Cayman Islands
- Fund holders
- 3
- Of which ETFs
- 1 2 other funds
- Value held
- 150K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 44,875 | 98.2K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 11,000 | 25.9K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 11,000 | 25.9K $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| State Street(R) SPDR(R) S&P(R) Emerging Markets Small Cap ETF SPDR INDEX SHARES FUNDS | 0.01 % | as of Jun 30, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
| Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 3 | +2 | 66,875 | +49.0 % |
| 2026Q2 | 1 | -1 | 44,875 | -36.3 % |
| 2026Q1 | 2 | 0 | 70,411 | 0.0 % |
| 2025Q4 | 2 | 0 | 70,411 | +48.5 % |
| 2025Q3 | 2 | 0 | 47,411 | 0.0 % |
| 2025Q2 | 2 | 0 | 47,411 | 0.0 % |
| 2025Q1 | 2 | 0 | 47,411 | -25.2 % |
| 2024Q4 | 2 | 0 | 63,411 | 0.0 % |
| 2024Q3 | 2 | 0 | 63,411 | -3.4 % |
| 2024Q2 | 2 | 0 | 65,617 | 0.0 % |
| 2024Q1 | 2 | 0 | 65,617 | +0.8 % |
| 2023Q4 | 2 | 65,113 |
Cite this page
Titelia. "Funds holding Gongwin Biopharm Holdings Co Ltd". https://titelia.com/en/stocks/gongwin-biopharm-holdings-co-ltd-KYG409471060